Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
NAD+ Depletion in Brain Blood Vessels Sparks Alzheimer's NeuroinflammationLongevity & Aging

NAD+ Depletion in Brain Blood Vessels Sparks Alzheimer's Neuroinflammation

Researchers discovered that amyloid beta (Aβ) depletes NAD+ in brain endothelial cells (BECs), causing mitochondrial DNA to leak into the cytosol and activate the cGAS/STING innate immune pathway. This cascade drives endothelial senescence, upregulates the NAD+-consuming enzyme CD38, and promotes a pro-inflammatory SASP that activates microglia via IL-6 signaling. In APP/PS1 Alzheimer's mice, supplementation with nicotinamide riboside (NR) restored NAD+ levels, suppressed cGAS/STING signaling, reduced neuroinflammation, improved vascular integrity, and rescued cognitive function—pointing to vascular NAD+ restoration as a compelling therapeutic strategy for Alzheimer's disease.

Deep Dive Audio
0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.